Jaypirca is a targeted therapy for CLL and other specific cancers. It is known as a Bruton’s tyrosine kinase inhibitor (BTK inhibitor). BTK is an enzyme that helps certain types of cancer cells ...

Truthfully, my longest relationship is one I entered by force and that constantly pulls me to my mirror to revel (and loathe) in the evidence of our love affair: hormonal acne. My years-long ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more If you have acne-prone skin or struggle with breakouts, you may know the benefits of retinol or pimple ...

Cystic-acne sufferers know that a cyst is not the same beast as your garden-variety pimple. While whitehead pimples sit on the surface of the skin (which, though unsightly, means they’re easier ...

There are a lot of [instances of] providing preliminary, very mild acne with really good treatment protocol for that patient, and they don't necessarily have to be seen in the office. What that ...

Inpatient dermatologic care costs over $5 billion annually, with significant potential for cost reduction through improved care models. Expanding inpatient dermatology services, including ...

If inflammation were a person, we’d picture her as a confident power woman, AirPods in and belting Mariah Carey’s “Why you so obsessed with meeee?” That’s because the wellness world is ...

Robert F. Kennedy Jr., laying out his early health agenda, said he would examine childhood vaccines, psychiatric drugs and other “formerly taboo” topics in investigating the causes of chronic ...

The 5-year relative survival rate for CML is 70%. Chronic lymphocytic leukemia (CLL) is most likely to affect people over age 55 years. It’s very rarely seen in children. According to the NCI ...

The American Society for Transplantation and Cellular Therapy ® (ASTCT ®) is pleased to announce David L. Porter, MD, as the Society's president for the 2025-2026 term. A long-standing leader in ...